• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIODYNAMICS, INC SMART PORT CT; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIODYNAMICS, INC SMART PORT CT; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Model Number H787CT96STSD0
Medical Device Problem Codes Malposition of Device (2616); Infusion or Flow Problem (2964)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/21/2016
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The device is not available to be returned to the manufacturer for evaluation.An investigation into the root cause for the event is currently in progress.The results of the investigation will be sent via a follow up medwatch.Reference: (b)(4).
 
Event or Problem Description
On or about on (b)(6) 2015, plaintiff underwent placement of an angiodynamics smartport product, reference number: ct96stsd; lot number: 4833030.The device was implanted by dr.(b)(6), for the purpose of providing venous access and for medications to treat her crohn's disease.(port 1 revision) upon information and belief, on (b)(6) 2016, dr.(b)(6) preoperative diagnosis for plaintiff was "poor venous access and need for port-a-cath with a malpositioned port".Dr.(b)(6) proceeded to perform a revision/replacement of the previously placed smartport.However, only the port hub was removed and replaced with a new port hub.The previously placed smartport catheter remained.Surgery was done at (b)(6).(b)(6).(port 1 removal, port 2 placement) on (b)(6) 2017, dr.(b)(6) removed the previous portacath and catheter and implanted a new smartport with reference number: ct96stsd; lot number: 5089596.This surgery was performed at (b)(6).Dr.(b)(6) preoperative diagnosis for (b)(6).Was "poor venous access with poorly functioning port-a-cath".(b)(6), 1317056-2025-00246) (port 2 removal, port 3 placement+) on (b)(6) 2018, dr.(b)(6) removed the smartport and implanted another new smartport with reference number: h787ct96stsd0; lot number: 5312598.This surgery was performed at (b)(6).Dr.(b)(6) preoperative diagnosis for plaintiff was a "malfunctioning port-a-cath".(b)(6), 1317056-2025-00247).On (b)(6) 2022, plaintiff had and office visit with dr.(b)(6) who is with (b)(6) system.(port 3 removal, replaced with competitor port 4) on (b)(6) 2022, dr.(b)(6) removed the last smartport and catheter and replaced it with a new portacath manufactured by a company other than angiodynamics.This surgery was performed at (b)(6).Dr.(b)(6) preoperative diagnosis for plaintiff, was "a nonfunctioning central venous catheter and access port." (b)(6), 1317056-2025-00248).Presently, the portacath implanted by dr.(b)(6) on (b)(6) 2022 is functioning well.
 
Additional Manufacturer Narrative
The customer's reported complaint description of port flipped in the port pocket cannot be confirmed given the patient centric nature of this event.No port product was returned to angiodynamics for evaluation since there was no reported port device malfunction, just port flipping in pocket.Port was in situ for treatment use for more than 20 months.A potential root cause for the port malposition/flipping is inadequate position (location and depth) of the port pocket and/or suturing of the port body to the underlying fascia.Device rotation and inadequate anchoring are cautioned in the device directions for use (dfu) as potential complication for an implanted port system.In addition, dfu states the following regarding port placement: placement needs to be supported by underlying bony structure.A minimum of three sutures should be used to secure port body.Avoid placing port too deep or too shallow (minimum 0.5 cm - maximum 2 cm under skin surface).A device history record (dhr) review of the indicated packaging lot revealed no quality related issues or manufacturing deficiencies at the time of manufacture.There have been no other reported complaints for the indicated packaging lot for similar port malposition issue.Labeling review: the directions for use (dfu) that is supplied with this port device contains the following statements: contraindications body size is insufficient to accommodate size of the port or the catheter.Warnings absence of a blood return or a poor blood return can be a sign of a potential complication such as occlusion, kinking, breakage, pinch-off syndrome, fibrin formation, thrombosis or malposition.This should be evaluated prior to device usage.A blood return should be present prior to usage of device for any therapy or testing.If the patient complains of pain, or if there is swelling when the device is flushed or when medication or contrast media is administered, evaluate the device for infiltration, proper needle placement, and potential complications such as occlusion, kinking, breakage, pinch-off syndrome, thrombosis or malposition.Failure to assess these complaints or observations can lead to device failure.Precautions: after any infusion, injection or bolus application, the system should be flushed with normal saline for injection or locked with a heparin solution per institutional protocol to prevent thrombotic occlusion of the catheter.Potential complications: use of an angiodynamics port system involves potential risks normally associated with the insertion or use of any implanted device or indwelling catheter including but not limited to: these complications are well documented in literature and should be considered when a venous access device is utilized.Catheter malposition; device rotation; implant rejection; inadequate anchoring.Port placement considerations: placement needs to be supported by underlying bony structure.A minimum of three sutures should be used to secure port body.Avoid placing port too deep or too shallow (minimum 0.5 cm - maximum 2 cm under skin surface).Post-operative care: the incision site should be monitored for signs of infection, inflammation, hematoma, device rotation or erosion.Routine wound care should be given to these sites.The smart port ct implantable port may be used immediately after verification of catheter placement.Instruct patient to avoid any heavy exertion or strenuous activity during the first few days after surgery.General guidelines: each access of an angiodynamics smart port ct implantable port should be performed using aseptic technique.Follow institutional universal precautions.A review of the angiodynamics complaint system noted no adverse trends for this complaint type and product family.This type of complaint continues to be monitored for trends.Reference (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SMART PORT CT
Common Device Name
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
ANGIODYNAMICS, INC
10 glens falls technical park
glens falls NY 12801
Manufacturer (Section G)
ANGIODYNAMICS, INC
10 glens falls technical park
glens falls NY 12801
Manufacturer Contact
alexandra invencio
26 forest street
marlborough, MA 01752
5086587990
MDR Report Key23090604
Report Number1317056-2025-00245
Device Sequence Number18768986
Product Code LJT
UDI-Device Identifier15051684018067
UDI-Public15051684018067
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
K062414
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2015
Device Explanted Year2016
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 12/22/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/30/2017
Device Model NumberH787CT96STSD0
Device Catalogue NumberCT96STSD
Device Lot Number4833030
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/20/2025
Supplement Date Received by Manufacturer12/19/2025
Initial Report FDA Received Date09/18/2025
Supplement Report FDA Received Date12/22/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured01/15/2015
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Reuse
Patient Sequence Number1
Patient SexFemale
-
-